About the Journal
Welcome to the International Journal of Current Research and Innovations in Pharma Sciences
Welcome to the International Journal of Current Research and Innovations in Pharma Sciences (IJCRIPS), an online biannual journal established in 2022. All articles are published in English, and we encourage original research papers, review articles, and letters to the editor.
The journal is proudly published under the stewardship of Mr. Ganesh Waghule, with its headquarters located at Deosade, Tq- Newasa, Ahmednagar, Maharashtra, India, 414604. The core mission of IJCRIPS is to provide a global platform for researchers in the field of pharmaceutical and biotechnological sciences. Our spectrum of interests covers formulation, bioanalytical, manufacturing, and evaluation of both conventional and novel dosage forms and drug products.
To maintain the high quality of our publications, we enforce a stringent review policy. Each submission undergoes a rigorous review process, ensuring we only publish content that meets our standards and contributes to the advancement of knowledge within the pharmaceutical sciences. Furthermore, we strictly adhere to UGC guidelines for checking plagiarism in articles, upholding the integrity of academic research.
For those interested in contributing, please refer to our submission guidelines for more information about the process. We look forward to receiving your valuable contributions and together, pushing the boundaries of pharmaceutical sciences.
IJCRIPS is dedicated to publishing innovative research papers, Review article and Case study with a focus on either experimental or theoretical aspects. We cover the following areas:
- Pharmaceutical Technology
- Pharmaceutical/Medicinal Chemistry
- Computational Chemistry and Molecular Drug Design
- Pharmacognosy and Phytochemistry
- Pharmaceutical Analysis
- Pharmacy Practice
- Clinical and Hospital Pharmacy
- Cell Biology
- Genomics and Proteomics
With our dedication to advancing and disseminating knowledge in the pharmaceutical sciences, we look forward to your valuable contributions.